Pharmcadd Co, Ltd announced that it has received $16 million in a round of funding on April 19, 2021. The transaction included participation from KB Securities Co., Ltd., Investment Arm, Maple Investment Partners, KDB Capital Corporation, Investment Arm, DSC Investments (Pty) Ltd, KTB Network Co., Ltd., SD BioSensor Inc., Samyang Holdings Corporation (KOSE:A000070), Huons Co., Ltd. (KOSDAQ:A243070), and DAYLI Partners Co., Ltd. The company has raised a total funding of $22 million till date.